Cesar Homero Gutiérrez-Aguirre, Olga Graciela Cantú-Rodríguez, Omar David Borjas-Almaguer, Oscar González-Llano, José Carlos Jaime-Pérez, Manuel Solano-Genesta, Miguel Gómez-Guijosa, Consuelo Mancias-Guerra, Luz Tarin, David Gómez-Almaguer. Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease. haematol [Internet]. 2012May3 [cited 2024Nov.22];97(5):717-22. Available from: https://haematologica.org/article/view/6297